B. Braun Medical and RyMed Technologies announced that they have entered into a long-term distribution agreement for the InVision-Plus Neutral IV Connector.
"The InVision-Plus Neutral IV Connector with Neutral Advantage Technology is designed to inhibit migration of bacteria into the fluid pathway, potentially improving patient outcomes, and enhancing clinician safety," said Tom Sutton, Vice President of Vascular Access Systems at B.Braun.
"This agreement will complement B.Braun’s current needleless connector portfolio offering to include a neutral displacement line of products," added Sutton.
The InVision-Plus Neutral IV Connector provides a priming volume of 0.027 mL. RyMed’s InVision-Plus platform of products provide a 10-point standard of features.
"We are extremely pleased to enter into this agreement with B.Braun, one of the finest companies in IV fluid delivery. RyMed first introduced neutral displacement technology to the market in 2004, and with this agreement, we will be able to offer the InVision-Plus System to a broader audience via B.Braun’s customers and GPO contracts," said Dana Ryan, President & CEO of RyMed Technologies.
B. Braun Medical, a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry.